186 related articles for article (PubMed ID: 12109133)
41. Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft.
Naumann N; De Ravin SS; Choi U; Moayeri M; Whiting-Theobald N; Linton GF; Ikeda Y; Malech HL
Gene Ther; 2007 Nov; 14(21):1513-24. PubMed ID: 17728796
[TBL] [Abstract][Full Text] [Related]
42. Genetic strategies for the treatment of sickle cell anaemia.
Mansilla-Soto J; Rivière I; Sadelain M
Br J Haematol; 2011 Sep; 154(6):715-27. PubMed ID: 21707580
[TBL] [Abstract][Full Text] [Related]
43. Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress.
Emery DW; Stamatoyannopoulos G
Ann N Y Acad Sci; 1999 Apr; 872():94-107; discussion 107-8. PubMed ID: 10372114
[TBL] [Abstract][Full Text] [Related]
44. Advances in Gene Therapy for Fanconi Anemia.
Río P; Navarro S; Bueren JA
Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
[TBL] [Abstract][Full Text] [Related]
45. Molecular control of cell cycle progression in primary human hematopoietic stem cells: methods to increase levels of retroviral-mediated transduction.
Dao M; Nolta J
Leukemia; 1999 Oct; 13(10):1473-80. PubMed ID: 10516745
[TBL] [Abstract][Full Text] [Related]
46. Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene.
Flasshove M; Bardenheuer W; Schneider A; Hirsch G; Bach P; Bury C; Moritz T; Seeber S; Opalka B
J Cancer Res Clin Oncol; 2000 Jul; 126(7):391-9. PubMed ID: 10929761
[TBL] [Abstract][Full Text] [Related]
47. Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells.
Masiuk KE; Brown D; Laborada J; Hollis RP; Urbinati F; Kohn DB
Mol Ther; 2017 Sep; 25(9):2163-2175. PubMed ID: 28663101
[TBL] [Abstract][Full Text] [Related]
48. Targeted gene therapy to antigen-presenting cells in the central nervous system using hematopoietic stem cells.
Lesniak MS; Kelleher E; Pardoll D; Cui Y
Neurol Res; 2005 Dec; 27(8):820-6. PubMed ID: 16354542
[TBL] [Abstract][Full Text] [Related]
49. Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned.
Morgan RA; Gray D; Lomova A; Kohn DB
Cell Stem Cell; 2017 Nov; 21(5):574-590. PubMed ID: 29100011
[TBL] [Abstract][Full Text] [Related]
50. [Safety of retroviral vectors in gene therapy].
Bogoslovskaia EV; Glazkova DV; Shipulin GA; Pokrovskiĭ VV
Vestn Ross Akad Med Nauk; 2012; (10):55-61. PubMed ID: 23240501
[TBL] [Abstract][Full Text] [Related]
51. Retroviral vector-mediated gene expression in hematopoietic cells.
Baum C; Richters A; Ostertag W
Curr Opin Mol Ther; 1999 Oct; 1(5):605-12. PubMed ID: 11249667
[TBL] [Abstract][Full Text] [Related]
52. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.
Zufferey R; Donello JE; Trono D; Hope TJ
J Virol; 1999 Apr; 73(4):2886-92. PubMed ID: 10074136
[TBL] [Abstract][Full Text] [Related]
53. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
54. Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients.
Amado RG; Mitsuyasu RT; Rosenblatt JD; Ngok FK; Bakker A; Cole S; Chorn N; Lin LS; Bristol G; Boyd MP; MacPherson JL; Fanning GC; Todd AV; Ely JA; Zack JA; Symonds GP
Hum Gene Ther; 2004 Mar; 15(3):251-62. PubMed ID: 15018734
[TBL] [Abstract][Full Text] [Related]
55. Delivery of genes to hematopoietic stem cells.
Onodera M
Methods Mol Biol; 2004; 246():527-39. PubMed ID: 14970614
[TBL] [Abstract][Full Text] [Related]
56. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells.
Barclay SL; Yang Y; Zhang S; Fong R; Barraza A; Nolta JA; Torbett BE; Abedi M; Bauer G; Anderson JS
Stem Cells; 2015 Mar; 33(3):870-9. PubMed ID: 25524029
[TBL] [Abstract][Full Text] [Related]
57. Short-term culture of human CD34+ cells for lentiviral gene transfer.
Santoni de Sio F; Naldini L
Methods Mol Biol; 2009; 506():59-70. PubMed ID: 19110619
[TBL] [Abstract][Full Text] [Related]
58. Gene therapy for haematopoietic and lymphoid disorders.
Kohn DB
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():54-7. PubMed ID: 9020937
[TBL] [Abstract][Full Text] [Related]
59. Gene transfer into hematopoietic stem cells using lentiviral vectors.
Scherr M; Eder M
Curr Gene Ther; 2002 Feb; 2(1):45-55. PubMed ID: 12108973
[TBL] [Abstract][Full Text] [Related]
60. Retroviral Transduction of Quiescent Murine Hematopoietic Stem Cells.
Park CS; Lacorazza HD
Methods Mol Biol; 2018; 1686():173-182. PubMed ID: 29030821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
